2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid LeukemiaChronic Disease, Disease Attributes, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute erythroid leukemia, acute megakaryoblastic leukemia, acute myeloid leukemia, anemia, bone marrow disorder, chronic myelomonocytic leukemia, hematologic disorder, leukemia, myelodysplastic syndrome, myelodysplastic syndrome with excess blasts, myelodysplastic syndrome with ring sideroblasts, myelodysplastic syndrome with single lineage dysplasia, myelodysplastic/myeloproliferative disease, myeloid leukemia, neoplasmActive, not recruitingPhase 1 / Phase 22026-08-07NCT00392353
Biocollection in MyeloDysplastic Syndrome (P-MDS)Chromosome Aberrations, Hemic and Lymphatic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, acute myeloid leukemia with multilineage dysplasia, bone marrow disorder, hematologic disorder, myelodysplastic syndrome, myelodysplastic syndrome associated with isolated del(5q), myelodysplastic syndrome with ring sideroblastsRecruitingNot applicable2026-06-25NCT04869683